Switching from One Biosimilar to Another Biosimilar of the Same Reference Biologic: A Systematic Review of Studies

ConclusionWithin the limitations of this systematic review, available data suggests that biosimilar-to-biosimilar switching is a safe and effective clinical practice, although it is not covered by current health authority regulations or guidance. No reduction in effectiveness or increase in adverse events was detected in biosimilar-to-biosimilar switching studies conducted to date.
Source: BioDrugs - Category: Drugs & Pharmacology Source Type: research